• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    |
    Weekly News Recap #Phispers
    Lilly to invest additional US$ 5.3 bn to boost obesity drug supply; FDA panel votes against Novo’s weekly insulin

    Lilly to invest additional US$ 5.3 bn to boost obesity drug supply; FDA panel votes against Novo’s weekly insulin

    This week’s Phispers comes packed with news of investments, acquisitions, deals and trials. Eli Lilly has more than doubl...

    Impressions : 1621

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.